Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Ex-Synageva team planning Kiniksa IPO

May 4, 2018 4:04 PM UTC

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) filed on April 27 to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush PacGrow.

Kiniksa Chairman and CEO Sanj Patel, President and COO Stephen Mahoney, CFO Chris Heberlig and Chief Legal Officer Thomas Beetham were all executives at Synageva BioPharma Corp., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in 2015 for about $9 billion (see BioCentury, May 18, 2015)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Kiniksa Pharmaceuticals Ltd.